{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:52:17Z","timestamp":1769637137502,"version":"3.49.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e \u00e0 Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e \u00e0 Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00204-022-03363-6","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T19:02:46Z","timestamp":1665428566000},"page":"201-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cells"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2775-3147","authenticated-orcid":false,"given":"Ana","family":"Reis-Mendes","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-3494","authenticated-orcid":false,"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-5119","authenticated-orcid":false,"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-4672","authenticated-orcid":false,"given":"Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-2756","authenticated-orcid":false,"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"1","key":"3363_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41389-017-0020-8","volume":"7","author":"C Aguirre-Hern\u00e1ndez","year":"2018","unstructured":"Aguirre-Hern\u00e1ndez C, Maya-Pineda H, Mill\u00e1n JS, Man YKS, Lu Y-J, Halld\u00e9n G (2018) Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad\u2206\u2206 through Bcl-2-dependent attenuation of autophagy. Oncogenesis 7(1):6","journal-title":"Oncogenesis"},{"issue":"4","key":"3363_CR2","first-page":"1879","volume":"45","author":"DS Alberts","year":"1985","unstructured":"Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL (1985) Disposition of mitoxantrone in cancer patients. Cancer Res 45(4):1879\u20131884","journal-title":"Cancer Res"},{"issue":"3","key":"3363_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jpba.2009.09.027","volume":"51","author":"G An","year":"2010","unstructured":"An G, Morris ME (2010) HPLC analysis of mitoxantrone in mouse plasma and tissues: application in a pharmacokinetic study. J Pharm Biomed Anal 51(3):750\u2013753","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"3363_CR4","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1039\/c2cs15328a","volume":"41","author":"KH Baek","year":"2012","unstructured":"Baek KH, Park J, Shin I (2012) Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 41(8):3245\u20133263","journal-title":"Chem Soc Rev"},{"issue":"3","key":"3363_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/jpet.110.173179","volume":"335","author":"OS Bains","year":"2010","unstructured":"Bains OS, Grigliatti TA, Reid RE, Riggs KW (2010) Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. J Pharmacol Exp Ther 335(3):533\u2013545","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"3363_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1211\/0022357991777010","volume":"51","author":"K Behnia","year":"1999","unstructured":"Behnia K, Boroujerdi M (1999) Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats. J Pharm Pharmacol 51(11):1275\u20131282","journal-title":"J Pharm Pharmacol"},{"key":"3363_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms22052401","volume":"22","author":"E Bik","year":"2021","unstructured":"Bik E, Mateuszuk L, Orleanska J, Baranska M, Chlopicki S, Majzner K (2021) Chloroquine-induced accumulation of autophagosomes and lipids in the endothelium. Int J Mol Sci 22:5","journal-title":"Int J Mol Sci"},{"key":"3363_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","volume":"452","author":"G Bj\u00f8rk\u00f8y","year":"2009","unstructured":"Bj\u00f8rk\u00f8y G, Lamark T, Pankiv S, \u00d8vervatn A, Brech A, Johansen T (2009) Monitoring autophagic degradation of p62\/SQSTM1. Methods Enzymol 452:181\u2013197","journal-title":"Methods Enzymol"},{"issue":"13","key":"3363_CR9","first-page":"3427","volume":"51","author":"J Blanz","year":"1991","unstructured":"Blanz J, Mewes K, Ehninger G et al (1991a) Isolation and structure elucidation of urinary metabolites of mitoxantrone. Cancer Res 51(13):3427\u20133433","journal-title":"Cancer Res"},{"issue":"5","key":"3363_CR10","first-page":"871","volume":"19","author":"J Blanz","year":"1991","unstructured":"Blanz J, Mewes K, Ehninger G et al (1991b) Evidence for oxidative activation of mitoxantrone in human, pig, and rat. Drug Metab Dispos 19(5):871\u2013880","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3363_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1073\/pnas.0610216104","volume":"104","author":"SM Bl\u00e4ttler","year":"2007","unstructured":"Bl\u00e4ttler SM, Rencurel F, Kaufmann MR, Meyer UA (2007) In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc Natl Acad Sci U S A 104(3):1045\u20131050","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3363_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.biochi.2010.09.015","volume":"93","author":"TB Br\u00fcck","year":"2011","unstructured":"Br\u00fcck TB, Br\u00fcck DW (2011) Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase. Biochimie 93(2):217\u2013226","journal-title":"Biochimie"},{"issue":"1","key":"3363_CR13","doi-asserted-by":"publisher","first-page":"15848","DOI":"10.1038\/s41598-019-52174-w","volume":"9","author":"B Bulutoglu","year":"2019","unstructured":"Bulutoglu B, Mert S, Rey-Bed\u00f3n C, Deng SL, Yarmush ML, Usta OB (2019) Rapid maturation of the hepatic cell line Huh7 via CDK inhibition for PXR dependent CYP450 metabolism and induction. Sci Rep 9(1):15848","journal-title":"Sci Rep"},{"issue":"12","key":"3363_CR14","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.4161\/auto.26336","volume":"9","author":"ML Chen","year":"2013","unstructured":"Chen ML, Yi L, Jin X et al (2013) Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy 9(12):2033\u20132045","journal-title":"Autophagy"},{"issue":"9","key":"3363_CR15","first-page":"4858","volume":"46","author":"FS Chiccarelli","year":"1986","unstructured":"Chiccarelli FS, Morrison JA, Cosulich DB et al (1986) Identification of human urinary mitoxantrone metabolites. Cancer Res 46(9):4858\u20134861","journal-title":"Cancer Res"},{"issue":"9","key":"3363_CR16","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1021\/tx400130v","volume":"26","author":"VM Costa","year":"2013","unstructured":"Costa VM, Carvalho F, Duarte JA, Bastos ML, Remi\u00e3o F (2013) The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol 26(9):1285\u20131311","journal-title":"Chem Res Toxicol"},{"issue":"12","key":"3363_CR17","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1007\/s00204-020-02874-4","volume":"94","author":"VM Costa","year":"2020","unstructured":"Costa VM, Capela JP, Sousa JR et al (2020) Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations. Arch Toxicol 94(12):4067\u20134084","journal-title":"Arch Toxicol"},{"issue":"1\u20132","key":"3363_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/B:MCBI.0000041848.57020.57","volume":"263","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM (2004) Autophagy: many paths to the same end. Mol Cell Biochem 263(1\u20132):55\u201372","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3363_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yjmcc.2005.03.003","volume":"39","author":"MM Davidson","year":"2005","unstructured":"Davidson MM, Nesti C, Palenzuela L et al (2005) Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 39(1):133\u2013147","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"3363_CR20","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.bbamcr.2008.12.011","volume":"1793","author":"GR De Meyer","year":"2009","unstructured":"De Meyer GR, Martinet W (2009) Autophagy in the cardiovascular system. Biochim Biophys Acta 1793(9):1485\u20131495","journal-title":"Biochim Biophys Acta"},{"key":"3363_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2161-0444.1000495","volume":"8","author":"PRO de Montellano","year":"2018","unstructured":"de Montellano PRO (2018) 1-Aminobenzotriazole: a mechanism-based cytochrome P450 inhibitor and probe of cytochrome P450 biology. Med Chem 8:3","journal-title":"Med Chem"},{"issue":"4","key":"3363_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2133\/dmpk.DMPK-12-RG-090","volume":"28","author":"Y Deng","year":"2013","unstructured":"Deng Y, Wang L, Yang Y et al (2013) In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6. Drug Metab Pharmacokinet 28(4):339\u2013344","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"3363_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00204-021-03204-y","volume":"96","author":"F Dion\u00edsio","year":"2022","unstructured":"Dion\u00edsio F, Ara\u00fajo AM, Duarte-Ara\u00fajo M et al (2022) Cardiotoxicity of cyclophosphamide\u2019s metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes. Arch Toxicol 96(2):653\u2013671","journal-title":"Arch Toxicol"},{"key":"3363_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tox.2015.01.006","volume":"329","author":"JL Dores-Sousa","year":"2015","unstructured":"Dores-Sousa JL, Duarte JA, Seabra V, Bastos ML, Carvalho F, Costa VM (2015) The age factor for mitoxantrone\u2019s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. Toxicology 329:106\u2013119","journal-title":"Toxicology"},{"issue":"4","key":"3363_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/bjc.1989.314","volume":"60","author":"SJ Duthie","year":"1989","unstructured":"Duthie SJ, Grant MH (1989) The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells. Br J Cancer 60(4):566\u2013571","journal-title":"Br J Cancer"},{"issue":"5","key":"3363_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2165\/00003088-199018050-00003","volume":"18","author":"G Ehninger","year":"1990","unstructured":"Ehninger G, Schuler U, Proksch B, Zeller KP, Blanz J (1990) Pharmacokinetics and metabolism of mitoxantrone A Review. Clin Pharmacokinet 18(5):365\u2013380","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"3363_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/med.21364","volume":"36","author":"BJ Evison","year":"2016","unstructured":"Evison BJ, Sleebs BE, Watson KG, Phillips DR, Cutts SM (2016) Mitoxantrone, more than just another topoisomerase II poison. Med Res Rev 36(2):248\u2013299","journal-title":"Med Res Rev"},{"issue":"6","key":"3363_CR28","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1016\/S0006-3495(97)78357-7","volume":"73","author":"A Feofanov","year":"1997","unstructured":"Feofanov A, Sharonov S, Fleury F, Kudelina I, Nabiev I (1997a) Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes. Biophys J 73(6):3328\u20133336","journal-title":"Biophys J"},{"issue":"6","key":"3363_CR29","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/S0006-3495(97)78356-5","volume":"73","author":"A Feofanov","year":"1997","unstructured":"Feofanov A, Sharonov S, Kudelina I, Fleury F, Nabiev I (1997b) Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis. Biophys J 73(6):3317\u20133327","journal-title":"Biophys J"},{"issue":"12 Suppl 6","key":"3363_CR30","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1212\/WNL.63.12_suppl_6.S15","volume":"63","author":"EJ Fox","year":"2004","unstructured":"Fox EJ (2004) Mechanism of action of mitoxantrone. Neurology 63(12 Suppl 6):S15\u2013S18","journal-title":"Neurology"},{"issue":"13","key":"3363_CR31","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.15252\/embj.201796697","volume":"36","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Baehrecke EH, Ballabio A et al (2017) Molecular definitions of autophagy and related processes. Embo j 36(13):1811\u20131836","journal-title":"Embo j"},{"issue":"1","key":"3363_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009871","volume":"8","author":"F Guan","year":"2019","unstructured":"Guan F, Yang X, Li J et al (2019) New molecular mechanism underlying myc-mediated cytochrome P450 2E1 upregulation in apoptosis and energy metabolism in the myocardium. J Am Heart Assoc 8(1):e009871","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"3363_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41419-020-03153-x","volume":"11","author":"Y Guan","year":"2020","unstructured":"Guan Y, Jiang S, Ye W et al (2020) Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy. Cell Death Dis 11(11):948","journal-title":"Cell Death Dis"},{"issue":"4","key":"3363_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/pr.55.4.2","volume":"55","author":"C Handschin","year":"2003","unstructured":"Handschin C, Meyer UA (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55(4):649\u2013673","journal-title":"Pharmacol Rev"},{"issue":"11","key":"3363_CR35","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1089\/ars.2010.3488","volume":"14","author":"N Hariharan","year":"2011","unstructured":"Hariharan N, Zhai P, Sadoshima J (2011) Oxidative stress stimulates autophagic flux during ischemia\/reperfusion. Antioxid Redox Signal 14(11):2179\u20132190","journal-title":"Antioxid Redox Signal"},{"key":"3363_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.12.006","volume":"165","author":"S Ikeda","year":"2022","unstructured":"Ikeda S, Zablocki D, Sadoshima J (2022) The role of autophagy in death of cardiomyocytes. J Mol Cell Cardiol 165:1\u20138","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"3363_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.78","volume":"4","author":"M Jin","year":"2013","unstructured":"Jin M, Ande A, Kumar A, Kumar S (2013) Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc\/jnk\/sp1 pathway. Cell Death Dis 4(3):e554","journal-title":"Cell Death Dis"},{"issue":"10","key":"3363_CR38","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1124\/dmd.108.022251","volume":"36","author":"N Kassner","year":"2008","unstructured":"Kassner N, Huse K, Martin HJ et al (2008) Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab Dispos 36(10):2113\u20132120","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3363_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0003-9861(76)90302-7","volume":"173","author":"JC Kawalek","year":"1976","unstructured":"Kawalek JC, Gilbertson JR (1976) Partial purification of the NADPH-dependent aldehyde reductase from bovine cardiac muscle. Arch Biochem Biophys 173(2):649\u2013657","journal-title":"Arch Biochem Biophys"},{"issue":"42","key":"3363_CR40","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1038\/sj.onc.1207936","volume":"23","author":"J Kluza","year":"2004","unstructured":"Kluza J, Marchetti P, Gallego MA et al (2004) Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 23(42):7018\u20137030","journal-title":"Oncogene"},{"issue":"1","key":"3363_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0891-5849(88)90058-5","volume":"5","author":"P Kolodziejczyk","year":"1988","unstructured":"Kolodziejczyk P, Reszka K, Lown JW (1988) Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone. Free Radic Biol Med 5(1):13\u201325","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"3363_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.RES.0000067471.95890.5C","volume":"92","author":"S Kostin","year":"2003","unstructured":"Kostin S, Pool L, Els\u00e4sser A et al (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92(7):715\u2013724","journal-title":"Circ Res"},{"issue":"2","key":"3363_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0009-2797(94)03603-6","volume":"97","author":"SJ Li","year":"1995","unstructured":"Li SJ, Rodgers EH, Grant MH (1995) The activity of xenobiotic enzymes and the cytotoxicity of mitoxantrone in MCF 7 human breast cancer cells treated with inducing agents. Chem Biol Interact 97(2):101\u2013118","journal-title":"Chem Biol Interact"},{"issue":"6","key":"3363_CR44","first-page":"1213","volume":"55","author":"YX Liao","year":"2019","unstructured":"Liao YX, Yu HY, Lv JY et al (2019) Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma. Int J Oncol 55(6):1213\u20131222","journal-title":"Int J Oncol"},{"issue":"6","key":"3363_CR45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11095-006-0277-7","volume":"23","author":"JH Lin","year":"2006","unstructured":"Lin JH (2006) CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 23(6):1089\u20131116","journal-title":"Pharm Res"},{"issue":"1","key":"3363_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1124\/dmd.108.024075","volume":"37","author":"CD Linder","year":"2009","unstructured":"Linder CD, Renaud NA, Hutzler JM (2009) Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator? Drug Metab Dispos 37(1):10\u201313","journal-title":"Drug Metab Dispos"},{"key":"3363_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu WJ, Ye L, Huang WF et al (2016) p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett 21:29","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"3363_CR48","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/cvr\/cvab112","volume":"118","author":"S Ljubojevi\u0107-Holzer","year":"2021","unstructured":"Ljubojevi\u0107-Holzer S, Kraler S, Djalinac N et al (2021) Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling. Cardiovasc Res 118(6):1492\u20131505","journal-title":"Cardiovasc Res"},{"issue":"8","key":"3363_CR49","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C et al (2018) Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14(8):1435\u20131455","journal-title":"Autophagy"},{"key":"3363_CR50","first-page":"153","volume-title":"methods in cell biology","author":"AJ McGahon","year":"1995","unstructured":"McGahon AJ et al (1995) The end of the (cell) line: methods for the study of apoptosis in vitro. In: Schwartz LW, Osborne BA (eds) methods in cell biology, vol 46. Academic Press, New York, pp 153\u2013185"},{"issue":"1","key":"3363_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10565-006-0143-8","volume":"23","author":"P Menna","year":"2007","unstructured":"Menna P, Minotti G, Salvatorelli E (2007) In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity. Cell Biol Toxicol 23(1):49\u201362","journal-title":"Cell Biol Toxicol"},{"key":"3363_CR52","doi-asserted-by":"crossref","unstructured":"Menon MB, Dhamija S (2018) Beclin 1 phosphorylation\u2014at the center of autophagy regulation. Front Cell Dev Biol 6:137","DOI":"10.3389\/fcell.2018.00137"},{"issue":"21","key":"3363_CR53","first-page":"5135","volume":"53","author":"K Mewes","year":"1993","unstructured":"Mewes K, Blanz J, Ehninger G, Gebhardt R, Zeller KP (1993) Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates. Cancer Res 53(21):5135\u20135142","journal-title":"Cancer Res"},{"issue":"12","key":"3363_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015666","volume":"5","author":"V Michaud","year":"2010","unstructured":"Michaud V, Frappier M, Dumas MC, Turgeon J (2010) Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism. PLoS ONE 5(12):e15666","journal-title":"PLoS ONE"},{"issue":"22","key":"3363_CR55","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861\u20132873","journal-title":"Genes Dev"},{"issue":"5","key":"3363_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A, Yamaguchi O, Takeda T et al (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13(5):619\u2013624","journal-title":"Nat Med"},{"issue":"12","key":"3363_CR57","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/0006-2952(94)00429-3","volume":"48","author":"C Panousis","year":"1994","unstructured":"Panousis C, Kettle AJ, Phillips DR (1994) Oxidative metabolism of mitoxantrone by the human neutrophil enzyme myeloperoxidase. Biochem Pharmacol 48(12):2223\u20132230","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"3363_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0304-3835(97)04611-9","volume":"113","author":"C Panousis","year":"1997","unstructured":"Panousis C, Kettle AJ, Phillips DR (1997) Neutrophil-mediated activation of mitoxantrone to metabolites which form adducts with DNA. Cancer Lett 113(1\u20132):173\u2013178","journal-title":"Cancer Lett"},{"issue":"3","key":"3363_CR59","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20(3):460\u2013473","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3363_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1389200216666151103114926","volume":"17","author":"AF Reis-Mendes","year":"2015","unstructured":"Reis-Mendes AF, Sousa E, de Lourdes BM, Costa VM (2015) The role of the metabolism of anticancer drugs in their induced-cardiotoxicity. Curr Drug Metab 17(1):75\u201390","journal-title":"Curr Drug Metab"},{"issue":"4","key":"3363_CR61","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00204-016-1839-z","volume":"91","author":"A Reis-Mendes","year":"2017","unstructured":"Reis-Mendes A, Gomes AS, Carvalho RA et al (2017) Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy. Arch Toxicol 91(4):1871\u20131890","journal-title":"Arch Toxicol"},{"key":"3363_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ph14060510","volume":"14","author":"A Reis-Mendes","year":"2021","unstructured":"Reis-Mendes A, Dores-Sousa JL, Padr\u00e3o AI et al (2021) Inflammation as a possible trigger for mitoxantrone-induced cardiotoxicity: an in vivo study in adult and infant mice. Pharmaceuticals 14:6","journal-title":"Pharmaceuticals"},{"issue":"7","key":"3363_CR63","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc 3(7):1125\u20131131","journal-title":"Nat Protoc"},{"issue":"2","key":"3363_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0006-2952(91)90484-M","volume":"41","author":"B Richard","year":"1991","unstructured":"Richard B, Fabre G, De Sousa G, Fabre I, Rahmani R, Cano JP (1991) Interspecies variability in mitoxantrone metabolism using primary cultures of hepatocytes isolated from rat, rabbit and humans. Biochem Pharmacol 41(2):255\u2013262","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3363_CR65","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00204-013-1040-6","volume":"87","author":"LG Rossato","year":"2013","unstructured":"Rossato LG, Costa VM, de Pinho PG et al (2013a) The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity. Arch Toxicol 87(10):1809\u20131820","journal-title":"Arch Toxicol"},{"issue":"4","key":"3363_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12012-013-9224-0","volume":"13","author":"LG Rossato","year":"2013","unstructured":"Rossato LG, Costa VM, Vilas-Boas V et al (2013b) Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event. Cardiovasc Toxicol 13(4):413\u2013425","journal-title":"Cardiovasc Toxicol"},{"issue":"2\u20133","key":"3363_CR67","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0960-0760(97)00027-7","volume":"62","author":"R Sampath-Kumar","year":"1997","unstructured":"Sampath-Kumar R, Yu M, Khalil MW, Yang K (1997) Metyrapone is a competitive inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 reductase. J Steroid Biochem Mol Biol 62(2\u20133):195\u2013199","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"3363_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16(1):46\u201356","journal-title":"Cell Death Differ"},{"issue":"6","key":"3363_CR69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00023210-200418060-00010","volume":"18","author":"LJ Scott","year":"2004","unstructured":"Scott LJ, Figgitt DP (2004) Mitoxantrone: a review of its use in multiple sclerosis. CNS Drugs 18(6):379\u2013396","journal-title":"CNS Drugs"},{"issue":"3","key":"3363_CR70","first-page":"550","volume":"53","author":"NG Shipp","year":"1993","unstructured":"Shipp NG, Dorr RT, Alberts DS, Dawson BV, Hendrix M (1993) Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells. Cancer Res 53(3):550\u2013556","journal-title":"Cancer Res"},{"issue":"6","key":"3363_CR71","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00432-014-1645-z","volume":"140","author":"AS Soares","year":"2014","unstructured":"Soares AS, Costa VM, Diniz C, Fresco P (2014) Combination of Cl-IB-MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR-dependent autophagy and mitotic catastrophe on human melanoma cells. J Cancer Res Clin Oncol 140(6):921\u2013935","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"3363_CR72","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcm.2012.05.015","volume":"21","author":"H Su","year":"2011","unstructured":"Su H, Wang X (2011) p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends Cardiovasc Med 21(8):224\u2013228","journal-title":"Trends Cardiovasc Med"},{"issue":"9","key":"3363_CR73","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1124\/dmd.111.039834","volume":"39","author":"Q Sun","year":"2011","unstructured":"Sun Q, Harper TW, Dierks EA et al (2011) 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase. Drug Metab Dispos 39(9):1674\u20131679","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3363_CR74","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4161\/auto.2608","volume":"2","author":"G Takemura","year":"2006","unstructured":"Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H (2006) Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2(3):212\u2013214","journal-title":"Autophagy"},{"key":"3363_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E (2008) LC3 and autophagy. Methods Mol Biol 445:77\u201388","journal-title":"Methods Mol Biol"},{"issue":"6","key":"3363_CR76","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.yjmcc.2006.03.428","volume":"40","author":"L Valentim","year":"2006","unstructured":"Valentim L, Laurence KM, Townsend PA et al (2006) Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia\/reperfusion injury. J Mol Cell Cardiol 40(6):846\u2013852","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3363_CR77","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/cddis.2009.16","volume":"1","author":"E Wirawan","year":"2010","unstructured":"Wirawan E, Vande Walle L, Kersse K et al (2010) Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis 1(1):e18\u2013e18","journal-title":"Cell Death Dis"},{"issue":"9","key":"3363_CR78","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/0006-2952(86)90127-9","volume":"35","author":"CR Wolf","year":"1986","unstructured":"Wolf CR, Macpherson JS, Smyth JF (1986) Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases. Biochem Pharmacol 35(9):1577\u20131581","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3363_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/10408449991349186","volume":"29","author":"LW Wormhoudt","year":"1999","unstructured":"Wormhoudt LW, Commandeur JN, Vermeulen NP (1999) Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29(1):59\u2013124","journal-title":"Crit Rev Toxicol"},{"issue":"3","key":"3363_CR80","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/096032719601500302","volume":"15","author":"MC Wright","year":"1996","unstructured":"Wright MC, Maurel P, Paine AJ (1996) Induction of cytochrome P450 3A by metyrapone in human hepatocyte culture. Hum Exp Toxicol 15(3):203\u2013204","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"3363_CR81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2019.10.114","volume":"521","author":"B Xie","year":"2020","unstructured":"Xie B, He X, Guo G et al (2020) High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement. Biochem Biophys Res Commun 521(1):232\u2013237","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03363-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:05:25Z","timestamp":1672938325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03363-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3363"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03363-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}